Abel Licon
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer Genomics and Diagnostics 5
-
- Acute Myeloid Leukemia Research 4
- Co-authors
- Michela Taufer (6 shared papers)Ming‐Ying Leung (4 shared papers)F. H. D. van Batenburg (1 shared paper)Alexander P. Gultyaev (1 shared paper)Trilce Estrada (1 shared paper)Kaylene J. Simpson (1 shared paper)Annaleen Vermeulen (2 shared papers)Žaklina Strezoska (2 shared papers)
- Journals
- Annals of Oncology (4 papers)Nature (1 paper)Parallel Computing (1 paper)npj Precision Oncology (1 paper)Cancer Research and Treatment (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Abel Licon
18 papers receiving 762 citations
Abel Licon's Hit Papers
Peers
Comparison fields: 5 of 51
- Hematology 346
- Cancer Research 212
- Genetics 76
- Public Health, Environmental and Occupational Health 114
- Pulmonary and Respiratory Medicine 122
Countries citing papers authored by Abel Licon
This map shows the geographic impact of Abel Licon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abel Licon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abel Licon more than expected).
Fields of papers citing papers by Abel Licon
This network shows the impact of papers produced by Abel Licon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abel Licon. The network helps show where Abel Licon may publish in the future.
Co-authors
The 25 scholars most cited alongside Abel Licon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease Hit paper breakdown → | 2019 | 352 |
| 2 | Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA Hit paper breakdown → | 2023 | 255 |
| 3 | 2008 | 48 | |
| 4 | 2012 | 29 | |
| 5 | 2015 | 24 | |
| 6 | 2021 | 22 | |
| 7 | 2024 | 12 | |
| 8 | 2006 | 11 | |
| 9 | 2020 | 9 | |
| 10 | 2008 | 8 | |
| 11 | A Dynamic Programming Algorithm for Finding the Optimal Segmentation of an RNA Sequence in Secondary Structure Predictions. | 2010 | 3 |
| 12 | 2008 | 3 | |
| 13 | 2007 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2016 | 1 | |
| 16 | 2016 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2015 | 1 | |
| 19 | 2026 | 0 |
About Abel Licon
Abel Licon is a scholar working on Cancer Research, Hematology, Molecular Biology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 19 papers that have together received 782 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (7 papers), Cancer Genomics and Diagnostics (5 papers), Acute Myeloid Leukemia Research (4 papers), Genomics and Phylogenetic Studies (4 papers), RNA modifications and cancer (4 papers), Bacteriophages and microbial interactions (2 papers), Lung Cancer Treatments and Mutations (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Hematology (346 citations), Cancer Research (212 citations), Genetics (76 citations), Public Health, Environmental and Occupational Health (114 citations) and Pulmonary and Respiratory Medicine (122 citations). Abel Licon has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Michela Taufer, Ming‐Ying Leung, F. H. D. van Batenburg, Alexander P. Gultyaev, Trilce Estrada, Kaylene J. Simpson, Annaleen Vermeulen, Žaklina Strezoska, Kevin A. M. Sullivan and Kruti M. Patel. Their work appears in journals such as Annals of Oncology, Nature, Parallel Computing, npj Precision Oncology and Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.